Skip to search formSkip to main contentSkip to account menu

INDIUM In 111 CAPROMAB PENDETIDE

Known as: 111-In Capromab Pendetide, indium (111In) capromab pendetide 
A radioimmunoconjugate consisting of the murine IgG1 kappa monoclonal antibody capromab (7E11-C5.3), conjugated to the linker-chelator glycyl-tyrosyl… 
National Institutes of Health

Related topics

Related topics

1 relation
Drug Allergy

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Evaluation of alternative methods for radiochemical purity testing of indium-111 capromab pendetide.
OBJECTIVE To evaluate alternative methods for radiochemical purity testing of indium (In)-111 capromab pendetide after the… 
2004
2004
Corrective 111In Capromab Pendetide SPECT Image Reconstruction Methods for Improved Detection of Recurrent Prostate Cancer
Abstract : It is generally recognized that (111)In capromab pendetide (PS) scans are technically challenging to perform and… 
2001
2001
False-positive 111 indium capromab pendetide scan due to benign myelolipoma.
2000
2000
111In-capromab pendetide: the evolution of prostate specific membrane antigen and the nuclear imaging of its 111In-labelled murine antibody in the evaluation of prostate cancer.
Each year, approximately 210,000 American men are diagnosed with prostate cancer and 41,800 die from the disease - numbers… 
Review
2000
Review
2000
Diagnostische und therapeutische Antikörper in der Onkologie — State of the Art
ZusammenfassungGrundlagen: Fortschritte in der rekombinanten Technologie, die Identifikation neuer Zielmoleküle sowie die M… 
2000
2000
111In-Capromab Pendetide
Each year, approximately 210 000 American men are diagnosed with prostate cancer and 41 800 die from the disease — numbers… 
1998
1998
All filter units are not alike: report of a problem encountered during preparation of indium-111 capromab pendetide.
To the Editor: Preparation of recently marketed radiolabeled antibody products involves filtration of the final product during… 
1998
1998
(111) INDIUM-CAPROMAB PENDETIDE IN THE EVALUATION OF PATIENTS WITH RESIDUAL OR RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY: EDITORIAL COMMENT
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)